ACLX FY 2020 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$32M

Net Income

-$32M

EPS (Diluted)

$-1.47

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$58M

Total Liabilities

$7M

Stockholders' Equity

$51M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$326,000	+100.0%
Operating Income	-$32M	-$18M	-78.6%
Net Income	-$32M	-$18M	-78.6%